Overview

A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Ziopharm
Treatments:
Ifosfamide
Isophosphamide mustard